Spike-specific T-cell responses in patients with COVID-19 successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2

OBJECTIVES: Neutralizing monoclonal antibodies (moAbs) improves clinical outcomes in patients with COVID-19 when administered during the initial days of infection. The action of moAbs may impair the generation or maintenance of effective immune memory, similar to that demonstrated in other viral dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Rotundo, Salvatore, Vecchio, Eleonora, Abatino, Antonio, Giordano, Caterina, Mancuso, Serafina, Tassone, Maria Teresa, Costa, Chiara, Russo, Alessandro, Trecarichi, Enrico Maria, Cuda, Giovanni, Costanzo, Francesco Saverio, Palmieri, Camillo, Torti, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477616/
https://www.ncbi.nlm.nih.gov/pubmed/36116671
http://dx.doi.org/10.1016/j.ijid.2022.09.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477616/
https://www.ncbi.nlm.nih.gov/pubmed/36116671
http://dx.doi.org/10.1016/j.ijid.2022.09.016

Ejemplares similares